163 related articles for article (PubMed ID: 29864287)
1. Small Delivery Vehicles of siRNA for Enhanced Cancer Targeting.
Kim HJ; Yi Y; Kim A; Miyata K
Biomacromolecules; 2018 Jul; 19(7):2377-2390. PubMed ID: 29864287
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in development of siRNA delivery vehicles for cancer therapy.
Kim HJ; Kim A; Miyata K; Kataoka K
Adv Drug Deliv Rev; 2016 Sep; 104():61-77. PubMed ID: 27352638
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
4. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
[TBL] [Abstract][Full Text] [Related]
5. Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Hatakeyama H; Wu SY; Mangala LS; Lopez-Berestein G; Sood AK
Methods Mol Biol; 2016; 1402():189-197. PubMed ID: 26721492
[TBL] [Abstract][Full Text] [Related]
6. Interfering cancer with polymeric siRNA nanomedicines.
Tiram G; Scomparin A; Ofek P; Satchi-Fainaro R
J Biomed Nanotechnol; 2014 Jan; 10(1):50-66. PubMed ID: 24724498
[TBL] [Abstract][Full Text] [Related]
7. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.
Lorenzer C; Dirin M; Winkler AM; Baumann V; Winkler J
J Control Release; 2015 Apr; 203():1-15. PubMed ID: 25660205
[TBL] [Abstract][Full Text] [Related]
8. The pH-Triggered Triblock Nanocarrier Enabled Highly Efficient siRNA Delivery for Cancer Therapy.
Du L; Zhou J; Meng L; Wang X; Wang C; Huang Y; Zheng S; Deng L; Cao H; Liang Z; Dong A; Cheng Q
Theranostics; 2017; 7(14):3432-3445. PubMed ID: 28912886
[TBL] [Abstract][Full Text] [Related]
9. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.
Lee JW; Choi J; Choi Y; Kim K; Yang Y; Kim SH; Yoon HY; Kwon IC
J Control Release; 2022 Nov; 351():713-726. PubMed ID: 36152808
[TBL] [Abstract][Full Text] [Related]
10. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
11. Porous silicon microparticles for delivery of siRNA therapeutics.
Shen J; Wu X; Lee Y; Wolfram J; Yang Z; Mao ZW; Ferrari M; Shen H
J Vis Exp; 2015 Jan; (95):52075. PubMed ID: 25651103
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.
Babu A; Muralidharan R; Amreddy N; Mehta M; Munshi A; Ramesh R
IEEE Trans Nanobioscience; 2016 Dec; 15(8):849-863. PubMed ID: 28092499
[TBL] [Abstract][Full Text] [Related]
13. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy.
Xu X; Wu J; Liu Y; Yu M; Zhao L; Zhu X; Bhasin S; Li Q; Ha E; Shi J; Farokhzad OC
Angew Chem Int Ed Engl; 2016 Jun; 55(25):7091-7094. PubMed ID: 27140428
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
[TBL] [Abstract][Full Text] [Related]
15. RNA Micelles for the Systemic Delivery of Anti-miRNA for Cancer Targeting and Inhibition without Ligand.
Yin H; Wang H; Li Z; Shu D; Guo P
ACS Nano; 2019 Jan; 13(1):706-717. PubMed ID: 30543397
[TBL] [Abstract][Full Text] [Related]
16. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.
Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK
J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900
[TBL] [Abstract][Full Text] [Related]
17. Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier.
Hu Y; Liu N; Cheng B; Tan Y; Wen L; Yuan H; Hu F
Oncotarget; 2016 Dec; 7(50):83258-83269. PubMed ID: 27825127
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.
Kim YD; Park TE; Singh B; Maharjan S; Choi YJ; Choung PH; Arote RB; Cho CS
Nanomedicine (Lond); 2015; 10(7):1165-88. PubMed ID: 25929572
[TBL] [Abstract][Full Text] [Related]
19. siRNA Targeting and Treatment of Gastrointestinal Diseases.
Chevalier R
Clin Transl Sci; 2019 Nov; 12(6):573-585. PubMed ID: 31309709
[TBL] [Abstract][Full Text] [Related]
20. A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy.
Jang M; Han HD; Ahn HJ
Sci Rep; 2016 Aug; 6():32363. PubMed ID: 27562435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
